Botelho Mónica C, Veiga Isabel, Oliveira Paula A, Lopes Carlos, Teixeira Manuel, da Costa José M Correia, Machado José C
INSA - National Institute of Health, Department of Health Promotion, Porto, Portugal ; IPATIMUP - Institute of Pathology and Molecular Immunology of Porto University, Porto, Portugal.
IPO - Portuguese Institute of Oncology, Department of Genetics, Porto, Portugal.
Adv Cancer Res Treat. 2013 Apr 28;2013.
is a parasitic flatworm that infects millions of people, mostly in the developing world, and is associated with high incidence of bladder cancer, although why is not clear. Previously, we have used CD-1 mice to show that total antigen (Sh) has a carcinogenic ability. Sh intravesically instillation induced the development of several urothelial lesions, namely nodular hyperplasia and dysplasia (LGIUN-Low Grade Intra-Urothelial Neoplasia) after 40 weeks of treatment. These results suggested that Sh induce urothelium malignization. Bladder carcinoma frequently harbours gene mutations that constitutively activate the receptor tyrosine kinase-Ras pathway for this reason we studied activating mutations in gene. Twenty percent of the bladders with dysplasia presented a mutation in codon 12 of exon 2. We concluded from these results that the parasite extract of has carcinogenic ability possibly through oncogenic mutation of gene.
是一种寄生扁虫,感染了数百万人,主要在发展中世界,并且与膀胱癌的高发病率相关,尽管原因尚不清楚。此前,我们使用CD-1小鼠表明总抗原(Sh)具有致癌能力。经40周治疗后,膀胱内灌注Sh可诱导多种尿路上皮病变的发展,即结节性增生和发育异常(LGIUN-低级别尿路上皮内瘤变)。这些结果表明Sh诱导尿路上皮恶性转化。膀胱癌经常存在组成性激活受体酪氨酸激酶-Ras途径的基因突变,因此我们研究了该基因中的激活突变。20%发育异常的膀胱在第2外显子的第12密码子处出现突变。我们从这些结果得出结论,该寄生虫提取物可能通过该基因的致癌突变而具有致癌能力。